Fujifilm (FUJIY)
(Delayed Data from OTC)
$10.87 USD
+0.14 (1.30%)
Updated Apr 24, 2024 03:59 PM ET
4-Sell of 5 4
B Value F Growth D Momentum D VGM
Company Summary
Tokyo-based FUJIFILM Holdings Corporation has a diversified business presence ranging from imaging (photoimaging, optics), healthcare and materials (high-performance materials, graphic systems/inkjet, recording media) solutions.
The company reported revenues of ¥2,859 billion, up 13.2% year over year in the fiscal year that ended Mar 31, 2023. Domestic and Overseas revenues were 35.9% and 64.1%, respectively.
FUJIFILM reports operations under four divisions - Imaging Solutions, Healthcare, Materials and Business Innovation Solutions.
Imaging Solutions (14.4% of total revenues for the fiscal year that ended Mar 31, 2023) has two sub-segments — Consumer Imaging and Professional Imaging.
<...
Company Summary
Tokyo-based FUJIFILM Holdings Corporation has a diversified business presence ranging from imaging (photoimaging, optics), healthcare and materials (high-performance materials, graphic systems/inkjet, recording media) solutions.
The company reported revenues of ¥2,859 billion, up 13.2% year over year in the fiscal year that ended Mar 31, 2023. Domestic and Overseas revenues were 35.9% and 64.1%, respectively.
FUJIFILM reports operations under four divisions - Imaging Solutions, Healthcare, Materials and Business Innovation Solutions.
Imaging Solutions (14.4% of total revenues for the fiscal year that ended Mar 31, 2023) has two sub-segments — Consumer Imaging and Professional Imaging.
Under Professional Imaging, the company manufactures and sells digital cameras, broadcasting cinema lenses, surveillance machine vision lenses, projector and digital signage.
Healthcare segment (32.1% of revenues) has three primary sub-segments —Medical Systems, Bio CDMO (contract development and manufacturing organisation) revenues and LS solutions.
Under this segment the company manufactures and markets medical equipment for diagnostic X-ray imaging, ultrasound systems, in-vitro diagnostics and CT/MRI. The company is integrating its core technologies with biotechnologies acquired through acquisitions to accelerate the growth of its Bio CDMO business.
Materials segment (24.2% of total revenues) further reports into four sub-segments — Electronic Materials, Graphic communication, Display Materials and other advanced materials.
Business Innovation segment (29.3% of total revenues) has two sub-segments — Office solutions and Business Solutions.
The earlier Document solution segment has been dissolved to form new Business Innovation segment. Consolidated sales are now reported separately for Office solutions and Business solutions. Also, the Production services included in the Document solution have now been combined with the Graphics communication of the Materials segment.
General Information
Fujifilm Holdings Corp
7-3 Akasaka 9-chome Minato-ku
Tokyo, M0 107-0052
Phone: 813-6271-1111
Fax: NA
Web: https://holdings.fujifilm.com
Email: NA
Industry | Semiconductor Equipment - Photomasks |
Sector | Computer and Technology |
Fiscal Year End | March |
Last Reported Quarter | 3/31/2024 |
Exp Earnings Date | 5/8/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | NA |
Current Year EPS Consensus Estimate | 0.63 |
Estimated Long-Term EPS Growth Rate | 8.10 |
Exp Earnings Date | 5/8/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 10.73 |
52 Week High | 70.98 |
52 Week Low | 10.42 |
Beta | 0.40 |
20 Day Moving Average | 93,175.15 |
Target Price Consensus | 13.80 |
4 Week | -6.33 |
12 Week | 1.79 |
YTD | 7.77 |
4 Week | -2.60 |
12 Week | -1.12 |
YTD | 3.74 |
Shares Outstanding (millions) | 2,487.75 |
Market Capitalization (millions) | 26,693.60 |
Short Ratio | NA |
Last Split Date | 6/4/1996 |
Dividend Yield | 0.96% |
Annual Dividend | $0.10 |
Payout Ratio | 0.14 |
Change in Payout Ratio | -0.03 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 15.82 |
Trailing 12 Months | 15.11 |
PEG Ratio | 1.94 |
vs. Previous Year | -1.95% |
vs. Previous Quarter | -0.98% |
vs. Previous Year | -1.58% |
vs. Previous Quarter | 3.12% |
Price/Book | 1.32 |
Price/Cash Flow | 9.97 |
Price / Sales | 1.28 |
3/31/24 | NA |
12/31/23 | 8.28 |
9/30/23 | 8.41 |
3/31/24 | NA |
12/31/23 | 5.49 |
9/30/23 | 5.58 |
3/31/24 | NA |
12/31/23 | 1.43 |
9/30/23 | 1.56 |
3/31/24 | NA |
12/31/23 | 0.91 |
9/30/23 | 1.01 |
3/31/24 | NA |
12/31/23 | 8.21 |
9/30/23 | 8.21 |
3/31/24 | NA |
12/31/23 | 8.21 |
9/30/23 | 8.21 |
3/31/24 | NA |
12/31/23 | 10.56 |
9/30/23 | 10.55 |
3/31/24 | NA |
12/31/23 | 8.13 |
9/30/23 | 8.26 |
3/31/24 | NA |
12/31/23 | 2.93 |
9/30/23 | 2.89 |
3/31/24 | NA |
12/31/23 | 0.08 |
9/30/23 | 0.08 |
3/31/24 | NA |
12/31/23 | 7.34 |
9/30/23 | 7.39 |